Kevin Freedman, MD
Sports Medicine · Bryn Mawr, PANPI 1730140153
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (41.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Vericel Corporation accounts for 61.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $12,068 and has fallen 74.7% since, to $3,059 in 2025. Among sports medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $311.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vericel Corporation$15K
- Liberty Surgical Inc.$4K
- Ferring Pharmaceuticals Inc.$2K
- Eclipse Technology Solutions Inc.$850
- Innocoll Pharmaceuticals Limited$768
- Arthrex$466
- plus $1K from 9 others
Across 19 payments — averaging $3526.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$60K
- Vericel Corporation$8K
What the payments were for
- Consulting fees$4,67519%
- Speaking & faculty fees$3,05013%
- Grants$10,00041%
- Travel & lodging$1,6887%
- Food & beverage$2,0849%
- Education$2,78111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vericel Corporation | 10 | $14,844 |
| Liberty Surgical Inc. | 5 | $3,623 |
| Ferring Pharmaceuticals Inc. | 23 | $2,383 |
| Eclipse Technology Solutions Inc. | 3 | $850 |
| Innocoll Pharmaceuticals Limited | 2 | $768 |
| Arthrex | 6 | $466 |
| Johnson & Johnson | 10 | $290 |
| Globus Medical | 1 | $250 |
| Zimmer Biomet | 4 | $244 |
| Bioventus LLC | 4 | $197 |
| Ossur Americas, Inc. | 1 | $191 |
| Smith+Nephew | 5 | $109 |
| Cumberland Pharmaceuticals, Inc. | 2 | $34 |
| Heraeus Medical, LLC. | 1 | $17 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$14,725
- EUFLEXXA$2,000
- XARACOLL$750
- CALIBER$250
- Unloader One X$191
How this compares
$24,277 in reported general payments places this provider in the 90th percentile of 311 sports medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 85 | $759 |
| Methylprednisolone | 15 | $65 |
| Amoxicillin | 22 | $47 |
| Meloxicam | 24 | $24 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Bryn Mawr
- Christopher DodsonBryn Mawr$20K
- Sam AkhavanPittsburgh$2.2M
- Albert LinPittsburgh$460K
- Sommer HammoudPhiladelphia$238K
- Theresa PazionisPhiladelphia$235K
- Matthew Varacallodu Bois$129K
- Matthew BestAllentown$77K
- Marco AlcalaCanonsburg$54K
- Brandon TaubergWashington$54K
- Alexander JohnsonBethlehem$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.